Automated Insulin Delivery System Improves Glycemic Control in Youth
THURSDAY, Dec. 12, 2024 -- Initiation of an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D), according to a study published in the January issue of Diabetes, Obesity and Metabolism.
Maaria Kiilavuori, M.D., from the University of Helsinki, and colleagues investigated the influence of an AID system on glycemic control in children and adolescents with T1D who do not reach optimal glycemic control with traditional treatment options (hemoglobin A1C >53 mmol/mol/7.0 percent). The analysis included 79 patients (aged 7 to 16 years) with T1D.
The researchers found that after the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. Between zero and three months, time in tight range and time in range increased (mean, 11.7 and 18.1 percent, respectively). During the same follow-up period, hemoglobin A1c and mean sensor glucose values decreased significantly. These effects were sustained at 12 and 24 months.
"Glycemic control in patients not reaching treatment goals improved significantly after the initiation of the AID system, and the favorable effect lasted throughout the follow-up," the authors write. "AID treatment could be an option for also those pediatric patients with T1D who do not have good skills in diabetes management."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Clinical Practice Guidelines Issued for Diabetes Distress
THURSDAY, Sept. 25, 2025 -- The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at the annual meeting of the...
Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment
MONDAY, Sept. 15, 2025 -- In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study...
Access to Modern Technologies, Insulin Affects HbA1c Levels in Pediatric Type 1 Diabetes
WEDNESDAY, Sept. 3, 2025 -- For children with type 1 diabetes (T1D), glycated hemoglobin (HbA1c) levels are associated with accessibility of modern diabetes technologies and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.